Madrigal Pharmaceuticals, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
MDGL on Nasdaq
Location
200 Barr Harbor Drive, Suite 400, West Conshohocken, PA

Insiders trading volume in the past year

Madrigal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director $1.15B +$353M +44.2% Jun 25, 2024
Rebecca Taub Pres., R&D, and CMO, Director $278M -$18.7M -6.29% Apr 8, 2024
Paul A. Friedman Director $236M -$24.5M -9.4% Jun 25, 2024
Fred B. Craves Director $92.2M -$4.79M -4.94% Sep 13, 2024
William John Sibold President and CEO, Director $16.6M -$1.55M -8.54% Sep 9, 2024
Alex G. Howarth Chief Financial Officer $5.74M Jan 23, 2024
Brian J. Lynch SVP and General Counsel $5.33M -$2.03M -27.6% Jan 23, 2024
Carole Huntsman Chief Commercial Officer $3.69M Jan 23, 2024
Remy Sukhija Chief Commercial Officer $3.66M Jan 16, 2023
Richard S. Levy Director $3.08M -$2.83M -47.9% Jun 25, 2024
Shannon T. Kelley General Counsel $2.23M Aug 15, 2024
Mardi Dier SVP and CFO $2.16M Mar 11, 2024
Robert E. Waltermire Senior VP, Chief Pharma Dev. $1.89M -$3.13M -62.4% Jun 14, 2024
James M. Daly Director $535K -$8.22M -93.9% Jun 25, 2024
Kenneth Bate Director $535K -$8.21M -93.9% Jun 25, 2024
Bay City Capital Llc 10%+ Owner $308K Dec 3, 2021
Raymond Cheong Director Jun 15, 2023
Keith R. Gollust Director Jun 16, 2022
David Milligan Director Jun 16, 2022

Recent Insider Transactions by Companies or Individuals for Madrigal Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.